Cargando…

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group

BACKGROUND: Recent advances in radiotherapy techniques have allowed ablative doses to be safely delivered to inoperable liver tumors. In this setting, proton beam radiotherapy (PBT) provides the means to escalate radiation dose to the target volume while sparing the uninvolved liver. This study eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parzen, Jacob S., Hartsell, William, Chang, John, Apisarnthanarax, Smith, Molitoris, Jason, Durci, Michael, Tsai, Henry, Urbanic, James, Ashman, Jonathan, Vargas, Carlos, Stevens, Craig, Kabolizadeh, Peyman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643436/ https://www.ncbi.nlm.nih.gov/pubmed/33148296 http://dx.doi.org/10.1186/s13014-020-01703-3

Ejemplares similares

Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial
por: Parzen, Jacob S., et al.
Publicado: (2021)

Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry
por: Eckstein, Jacob, et al.
Publicado: (2023)

Proton Therapy for Skull-Base Chordomas and Chondrosarcomas: Initial Results From the Beaumont Proton Therapy Center
por: Parzen, Jacob S, et al.
Publicado: (2021)

Optimization of Field Design in the Treatment of Rectal Cancer with Intensity Modulated Proton Beam Radiation Therapy: How Many Fields Are Needed to Account for Rectal Distension Uncertainty?
por: Parzen, Jacob S., et al.
Publicado: (2021)

Feasibility study: spot-scanning proton arc therapy (SPArc) for left-sided whole breast radiotherapy
por: Chang, Sheng, et al.
Publicado: (2020)

The Role of Hypofractionation in Proton Therapy
por: Santos, Alexandre, et al.
Publicado: (2022)

Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registry
por: Han, James E., et al.
Publicado: (2020)

Redefine the role of range shifter in treating bilateral head and neck cancer in the era of Intensity Modulated Proton Therapy
por: Ding, Xuanfeng, et al.
Publicado: (2018)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
por: Johansson, Silvia, et al.
Publicado: (2012)

Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study
por: Liu, Gang, et al.
Publicado: (2020)

Linear Energy Transfer Incorporated Spot-Scanning Proton Arc Therapy Optimization: A Feasibility Study
por: Li, Xiaoqiang, et al.
Publicado: (2021)

Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy
por: Li, Xiaoqiang, et al.
Publicado: (2018)

A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors
por: Yu, Nathan Y., et al.
Publicado: (2019)

Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry
por: Saeed, Ali M., et al.
Publicado: (2020)

Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023)

Proton beam radiotherapy for esophagus cancer: state of the art
por: Gergelis, Kimberly R., et al.
Publicado: (2020)

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2022)

Comparing Predicted Toxicities between Hypofractionated Proton and Photon Radiotherapy of Liver Cancer Patients with Different Adaptive Schemes
por: Nenoff, Lena, et al.
Publicado: (2023)

Hypofractionated Stereotactic Radiotherapy after Transarterial Chemoembolisation Failure in an Unresectable Hepatocellular Carcinoma: A Case Presentation
por: Fiorica, Francesco, et al.
Publicado: (2013)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer
por: Vargas, Carlos E., et al.
Publicado: (2018)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy
por: Borowicz, Dorota Maria, et al.
Publicado: (2021)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Hypofractionated radiotherapy for elderly breast cancer patients: from early stages disease to local palliation for unresectable disease
por: Nair, Vimoj J., et al.
Publicado: (2020)

FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification
por: Wei, Shouyi, et al.
Publicado: (2022)

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose
por: Hong, ZhengShan, et al.
Publicado: (2023)

Hypofractionated Radiotherapy for 35 Patients with Adrenal Metastases: A Single-Institution Experience
por: Zhao, Ruizhi, et al.
Publicado: (2020)

Hypofractionated radiotherapy in breast cancer: a 10-year single institution experience
por: Najas, Gabriel Faria, et al.
Publicado: (2021)

Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome
por: Dubinsky, Pavol, et al.
Publicado: (2023)

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation
por: Ha, Boram, et al.
Publicado: (2019)

Proton radiotherapy accelerators
por: Wieszczycka, Wioletta, et al.
Publicado: (2001)

Proton Radiotherapy Workshop
por: Blattmann, H.
Publicado: (1991)

Reirradiation for Rectal Cancer Using Pencil Beam Scanning Proton Therapy: A Single Institutional Experience
por: Koroulakis, Antony, et al.
Publicado: (2020)

Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry
por: Jongen, Aurélien, et al.
Publicado: (2021)

Proton re-irradiation of unresectable recurrent head and neck cancers
por: Gordon, Konstantin, et al.
Publicado: (2021)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Proton Therapy Outcomes for Head and Neck Cutaneous Melanoma: Proton Collaborative Group Analysis
por: Han, James E., et al.
Publicado: (2022)

Primary chondrosarcomas of the larynx treated with proton radiotherapy: A single institutional experience
por: Mahase, Sean S., et al.
Publicado: (2022)

Hidradenocarcinoma of the Abdominal Wall Treated With Wide Surgical Excision and Adjuvant Radiotherapy
por: Rehman, Rafey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cv71nqhaa2ir7kqddg8c1eo2ma